Combination Study of Antibiotics With Enzalutamide (PROMIZE)
Conditions
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Interventions
- DRUG: Enzalutamide 40mg
- DRUG: Amoxicillin 500mg
- DRUG: Metronidazole 400mg
- DRUG: Vancomycin 125mg
- DRUG: Ciprofloxacin 500g
Sponsor
Institute of Cancer Research, United Kingdom
Collaborators